Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Lokmanya & Excel Life Sciences Collaborate for Expansion of Clinical Trials Services within the Lokmanya Research Network

The collaboration is part of a larger initiative and commitment at these organizations to improve access and expand the clinical research to trial naive physicians & sites. The alliance will focus on comprehensive management and streamlining the process, systems and procedures for conducting clinical trials at Lokmnaya. Specifically, ELS will provide dedicated, highly trained clinical research coordinator to busy Lokmanya clinical investigators to support them with all aspects of day to day study conduct. This collaboration emphasizes both organizations strong focus and priority on the ethical conduct of clinical trials and patient care. Please click here to read the full press release.

 

 

Latest News

The Incredible Shrinking Salesforce? Not Everywhere - Big Drugmakers Like Boehringer Ingelheim Corporation, Novo Nordisk A/S are Still Hiring!

Allergan Inc. to Build R&D Plant, Add 400 Jobs in New Jersey

Men Think Meat is Macho and Salad is for Wimps, University of Pennsylvania Study

Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund

It's Not Just What You Eat, It's When You Eat, Salk Institute for Biological Studies Study

Johnson & Johnson Recalls Nearly 54,000 Packages of Imodium

Statins May Help Healthy Adults, Oxford University Study

Being Obese May Make Job Search Tougher, University of Hawaii Study

With Fat: What's Good or Bad for the Heart, May be the Same for the Brain, Brigham and Women's Hospital Study

Osiris Therapeutics, Inc. Wins Canadian Approval for First Stem-Cell Therapy

GlaxoSmithKline's Melanoma Cocktail Slows Cancer in Study

Rare Gene Variants Making Drug Discovery Difficult, University of Washington

Ocera Therapeutics, Inc. Receives CE Mark for Zysa??? for the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-d)

FDA OKs Multiple Companies to Sell Generic Plavix as Drug Falls Off Patent Cliff

Parents are Happier People Than Non-parents, University of California, Riverside Study

Dendreon Corporation Shares Fall; SEC Probe, Rival Drug May be Reasons

Mylan Pharmaceuticals, Inc.'s Generic Version of Blood-Thinner Plavix Gets FDA Approval

Government Retains UK's Strict Animal Testing Regime

Warner Chilcott, PLC Sues Watson Pharmaceuticals, Inc. Over Generic Contraceptive

Panel Debates: Should We Test Anthrax Vaccine On Kids?

Training the Brain Could Help Reduce Pain, University of South Australia Study

Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses

China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO

Pfizer Inc.'s Popular Antibiotic May Raise Risk of Sudden Death

Agilent Technologies, Inc. (Santa Clara, California) to Acquire Dako A/S for $2.2 Billion

Acorda Therapeutics to FDA: What Deadlines?

Human Genome Sciences, Inc. Board Adopts Poison Pill Antitakeover Plan, in Talks With Potential Suitors

Amgen Revives Defunct Drug for New Cures

Pfizer Inc. Lung Drug Stops Deadly Child Cancers in Study

Bristol-Myers Squibb Company Exec Writes Book for Punishment

Kythera Biopharmaceuticals Files for $86.3 Milion IPO

Boehringer Ingelheim Corporation Reports Convincing Data for Lung Cancer Therapy

New Novartis AG COPD Drug Beats Placebo Over a Year

Coffee Drinkers More Likely to Live Longer, National Cancer Institute Study

Children With Cancer Have Complete Responses in a COG Phase 1 Trial: Pills Zero in On Abnormal Genes That Drive Specific Cancers, Children's Hospital of Philadelphia Study

Tolerability of Astellas Pharma Inc. Kidney Cancer Drug Impresses

Old Films to Help Recover People's Forgotten Past, Study

Want to Avoid Erectile Dysfunction Following Prostate Cancer Surgery? University of California, Los Angeles (UCLA) Study

FDA Warning Hurts Hikma Pharmaceuticals Generics Margins

Johnson & Johnson's Zytiga Helps Eliminate Early-Stage Prostate Cancer

Ethical Questions Surround New At-Home HIV Test

Roche's Genentech to Take Part in First-ever Alzheimer's Prevention Trial

Not All "Good Cholesterol" Is "Good," Massachusetts General Hospital Study

Alzheimer's Gene Causes Brain's Blood Vessels to Leak Toxins and Die, University of Rochester Study

Array BioPharma, Inc. Shares Rise on Lung Cancer, Melanoma Results

Wellcome Trust Sanger Institute Researchers Describe 9 New Genes That Drive the Development of Breast Cancer

Biologists Produce Potential Malarial Vaccine from Algae, University of California, San Diego (UCSD) Study

Does Sugar Make You Stupid?, University of California, Los Angeles (UCLA) Study

Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate Tumors, Dana-Farber Cancer Institute Study

Newron Pharmaceuticals PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed

Why Omega-3 Oils Help At the Cellular Level, University of California, San Diego (UCSD) Study

Infant Head Lag May Signal Autism, Kennedy Krieger Institute Study

Pfizer Inc. Cuts 50 Jobs at Estrogen Facility

Takeda Pharmaceutical Co. Ltd. Open to More M&A Deals

Merck KGaA Targets $385 Million in Cost Cuts by 2014 as Geneva Protests Continue

Piramal Healthcare Limited to Buy US Drug Data Firm for $635 Million

Boudazin Named President and CEO of Boiron

Two-Drug Combo Helps Teens With Migraines, GlaxoSmithKline Reveals

A Little More Education, a Little Longer Life? Study

How Payers View Pfizer Inc.'s Rheumatoid Arthritis Pill

Pfizer Inc.'s Torisel Fails Phase III Renal Cell Carcinoma Study in Showdown Against Bayer HealthCare's Nexavar

Scientist Was Cheated Out of Recognition, Book Says

Feeding Tube May Flare Some Ulcer Risks, Brown University Study

Why Both Men and Women View Women in Sexy Ads as Objects, Not Humans, Universit?? Libre de Bruxelles Study

Ra Pharma Closes $8.6 Million Second Tranche of $27 Million Series A

Mice With Big Brains Provide Insight Into Brain Regeneration and Developmental Disorders, University of Ottawa Study

National Institute for Clinical Excellence (NICE) Reverses Earlier Decision, Backs Johnson & Johnson's Zytiga

Mystery Gene Reveals New Mechanism for Anxiety Disorders, University of Chicago Study

Genes Might Be Key to Parkinson's Spread, University of California, Los Angeles (UCLA) Study

Lundbeck Inc. Soars on Phase 3 Study Results for Experimental Antidepressant

Looks Matter More Than Reputation When It Comes to Trusting People With Our Money, University of Warwick Study

Early Biomarker for Pancreatic Cancer Identified, University of California, San Diego (UCSD) Study

Girls Take Longer to Heal From Concussions, Michigan State University Study

Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Sleepwalking Linked to Depression, Anxiety, Stanford University School of Medicine Study

Hospira, Inc. Recalls Pain Drug Cartridges

Gene Therapy Dramatically Extends Mouse Lifespan, Study

Massachusetts Life Sciences Center Release: Breaks Ground on First in the Nation Biomanufacturing Center; Creating 10 Permanent Jobs

AstraZeneca PLC Slashes 400 More Jobs in Sweden

Breakthrough in Bile Duct Cancer With Discovery of New Gene Mutations, Van Andel Institute Study

Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer Inc., AstraZeneca PLC, Sanofi (France)

Cornerstone Therapeutics Inc. to Acquire EKR Therapeutics, Inc. for $125 Million Cash, Plus $25 Million in Milestones

GlaxoSmithKline to Fully Buy Cellzome AG for $99 Million

Roche Bets on an Alzheimer's Drug

Cross-Reactivity Between Peanuts and Other Legumes Can Lead to Serious Allergic Reactions, Norwegian School of Veterinary Science Study

Gamida Cell Ltd. Raises $10 Million to Progress Phase III-Stage Hematologic Cancer Cell Therapy

Achillion Pharmaceuticals, Inc.'s Hepatitis C Drug Gets FDA Fast Track

Mayo Clinic Researchers Discover Biomarkers for Prostate Cancer Detection, Recurrence

Scil Proteins GmbH, Ono Pharmaceutical Company, Ltd. Establish Affilin Therapeutics Discovery and Development Collaboration

Promedior Moves Fibrosis Pipeline to Boston, Hires Shire plc Vet as CEO

US Launches Ambitious Plan to Research Alzheimer???s Treatments

Watson Pharmaceuticals, Inc. Shuts Down Groveport Warehouse, Lays Off 55

Playful Games Promote Reading Development, University of Gothenburg Study

Furiex Pharmaceuticals, Inc. Says Johnson & Johnson Returns Sexual Dysfunction Drug Rights

Concern at Psychiatric Drugs Used on Children, University of Adelaide Study

FDA Says Unsure if Novartis AG MS Pill Caused Deaths

Takeda Pharmaceutical Co. Ltd. Phase III Crohn's Disease Trial Meets Primary Endpoints

Stiefel Laboratories Receives FDA Approval of Fabior??? Foam, 0.1%

Ventrus Biosciences, Inc. Unveils Positive Results of Its Phase 3 Trial of Diltiazem

Brain Circuitry is Different for Women With Anorexia and Obesity, University of Colorado Study

Gilead Sciences, Inc.' HIV Quad Pill Wins Backing From FDA Advisers

Touch Sensitivity is Genetically Linked to Hearing, Max Delbruck Center Study

Genetic Test Identifies Eye Cancer Tumors Likely to Spread, Washington University in St. Louis Study

Bristol-Myers Squibb Company and Tsinghua University Enter Strategic Partnership

Drug Kills Cancer Cells by Restoring Faulty Tumor Suppressor, Reveals

Novel Approach to Stimulate Immune Cells, Rutgers University Study

OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO

Going, Going, Gone. Pfizer Inc. Eliminates Pensions

American Society of Clinical Oncology Preview: Eight Cancer Drugs to Watch at the Big Show

Opko Health, Inc. Catches Investors' Attention With Alzheimer's Test

Maxygen, Inc. Gets $30 Million Payment From Bayer HealthCare

Servier on Trial Over Diabetes-Diet Pill

Gene Therapy for Hearing Loss: Potential and Limitations, Emory University School of Medicine Study

JumpStart to Create 40 More Top Quality Jobs for Scientific and Business Talent

Red Wine Compound Can Combat Alzheimer???s, Georgetown University Medical Center Study

Combo Therapy Reverses Diabetes in Mice, University of Florida Study

High-Fat Diet Lowered Blood Sugar and Improved Blood Lipids in Diabetics, Link??ping University Study

Arena Pharmaceuticals, Inc. Wins Positive FDA Panel Vote for Obesity Drug

Vitamin K2: New Hope for Parkinson's Patients? Flanders Institute for Biotechnology Study

Maternal Gluten Sensitivity Linked to Schizophrenia Risk in Children, Johns Hopkins University Study

Can Getting Sick Give You Cancer? New Research Says Sometimes, Yes, Reveals

Blood Pressure Drugs Don't Protect Against Colorectal Cancer, Reveals

Inside the Secret World of Drug Company Rebates

PolyMedix Inc. Stops Studies on Anti-coagulant Reversing Agent

Researcher Death Highlights Dangers of Pathogen Work, Reveals

Upcoming Events

    Read more..

222


    Read more..
Search
Search :